Julie Collins
Overview
Explore the profile of Julie Collins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jakkaraddi B, Araujo L, Weinberg A, Kaur R, Collins J
Perfusion
. 2025 Jan;
:2676591251317679.
PMID: 39886882
: Medical mission trips address the global burden of cardiac disease, particularly in Sub-Saharan Africa, where limited access to cardiac surgery exacerbates challenges faced by affected individuals. However, a lack...
2.
Bhardwaj R, Collins J, Madonia J, Matschke K, Bertz R, Liu J
Headache
. 2024 Nov;
65(1):14-23.
PMID: 39501702
Objective: The potential for drug-drug interaction of multiple-dose intranasal zavegepant on the single-dose oral contraceptive ethinyl estradiol and levonorgestrel (EE-LNG) was evaluated. Background: Zavegepant (as a nasal spray) is a...
3.
Lynce F, Mainor C, Donahue R, Geng X, Jones G, Schlam I, et al.
Nat Commun
. 2024 May;
15(1):3957.
PMID: 38730268
No abstract available.
4.
Lynce F, Mainor C, Donahue R, Geng X, Jones G, Schlam I, et al.
Nat Commun
. 2024 Mar;
15(1):2691.
PMID: 38538574
Chemotherapy and immune checkpoint inhibitors have a role in the post-neoadjuvant setting in patients with triple-negative breast cancer (TNBC). However, the effects of nivolumab, a checkpoint inhibitor, capecitabine, or the...
5.
Lynce F, Mainor C, Donahue R, Geng X, Jones G, Schlam I, et al.
medRxiv
. 2023 Dec;
PMID: 38105958
Chemotherapy and immune checkpoint inhibitors have a role in the post-neoadjuvant setting in patients with triple-negative breast cancer (TNBC). However, the effects of nivolumab, a checkpoint inhibitor, capecitabine, or the...
6.
Roy T, Barrows E, Mainor C, Collins J, Lynce F, Isaacs C, et al.
Contemp Clin Trials Commun
. 2023 Apr;
33:101110.
PMID: 37026029
Standard treatment for metastatic hormone positive (HR+) breast cancer includes a combination of a CDK4/6 inhibitor and antiestrogen therapy. Despite durable responses, eventual endocrine resistance results in disease progression. The...
7.
Harnish J, Beyer K, Collins J
J Extra Corpor Technol
. 2022 Aug;
54(2):153-160.
PMID: 35928334
Pediatric patients undergoing cardiopulmonary bypass (CPB) require adequate anticoagulation to combat hemostatic activation. Heparin is used to bind and catalyze antithrombin III (ATIII) that works to inhibit clot formation. To...
8.
Protasio A, van Dongen S, Collins J, Quintais L, Ribeiro D, Sessler F, et al.
PLoS Negl Trop Dis
. 2022 Jun;
16(6):e0010521.
PMID: 35666710
[This corrects the article DOI: 10.1371/journal.pntd.0005559.].
9.
Collins J, Westerveld R, Nelson K, Rohan H, Bower H, Lazenby S, et al.
BMJ Glob Health
. 2021 Sep;
6(9).
PMID: 34535490
Introduction: COVID-19 vaccines are now being distributed to low- and middle-income countries (LMICs), with global urgency surrounding national vaccination plans. LMICs have significant experience implementing vaccination campaigns to respond to...
10.
Smaghi B, Collins J, Dagina R, Hiawalyer G, Vaccher S, Flint J, et al.
Int J Infect Dis
. 2021 May;
110 Suppl 1:S17-S24.
PMID: 33991678
Objective: We aimed to identify the barriers and enablers that Health Care Workers (HCWs) in Papua New Guinea experienced in swabbing for COVID-19. Methods: We conducted a cross-sectional multi-methods study:...